VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,691,054 | -10.6% | 100,002 | 0.0% | 0.05% | -8.5% |
| Q2 2023 | $3,011,060 | -6.5% | 100,002 | +0.5% | 0.06% | -19.2% |
| Q1 2023 | $3,218,890 | +7.1% | 99,502 | -5.1% | 0.07% | +4.3% |
| Q4 2022 | $3,006,491 | +17.0% | 104,902 | -1.5% | 0.07% | +2.9% |
| Q3 2022 | $2,569,000 | -13.2% | 106,532 | -1.4% | 0.07% | -5.6% |
| Q2 2022 | $2,958,000 | -37.2% | 108,032 | -12.0% | 0.07% | -29.4% |
| Q1 2022 | $4,707,000 | +19.7% | 122,753 | +0.0% | 0.10% | +20.0% |
| Q4 2021 | $3,931,000 | +26.1% | 122,704 | +16.0% | 0.08% | +18.1% |
| Q3 2021 | $3,118,000 | -36.9% | 105,790 | -27.3% | 0.07% | -36.8% |
| Q2 2021 | $4,942,000 | +7.7% | 145,424 | +3.0% | 0.11% | -9.5% |
| Q1 2021 | $4,590,000 | -7.7% | 141,222 | +2.3% | 0.13% | -24.6% |
| Q4 2020 | $4,971,000 | +30.1% | 138,017 | +41.5% | 0.17% | +10.6% |
| Q3 2020 | $3,820,000 | +49.3% | 97,550 | +39.8% | 0.15% | +43.8% |
| Q2 2020 | $2,559,000 | +42.3% | 69,765 | -10.6% | 0.10% | +11.7% |
| Q1 2020 | $1,798,000 | -17.9% | 78,042 | +4.3% | 0.09% | +9.3% |
| Q4 2019 | $2,191,000 | +33.8% | 74,827 | +22.0% | 0.09% | +30.3% |
| Q3 2019 | $1,638,000 | -27.4% | 61,336 | -30.5% | 0.07% | -22.4% |
| Q2 2019 | $2,256,000 | +21.9% | 88,276 | +6.9% | 0.08% | +32.8% |
| Q1 2019 | $1,851,000 | +10.9% | 82,596 | +4.4% | 0.06% | +8.5% |
| Q4 2018 | $1,669,000 | +13.1% | 79,136 | -0.7% | 0.06% | +40.5% |
| Q3 2018 | $1,476,000 | -54.2% | 79,714 | -44.9% | 0.04% | -54.3% |
| Q2 2018 | $3,226,000 | -6.8% | 144,589 | -8.2% | 0.09% | -8.9% |
| Q1 2018 | $3,462,000 | +74.8% | 157,529 | +84.9% | 0.10% | +77.2% |
| Q4 2017 | $1,980,000 | +2.4% | 85,209 | +1.3% | 0.06% | +3.6% |
| Q3 2017 | $1,933,000 | -19.0% | 84,132 | -22.2% | 0.06% | -17.9% |
| Q2 2017 | $2,386,000 | +112.8% | 108,092 | +120.0% | 0.07% | +123.3% |
| Q1 2017 | $1,121,000 | -76.4% | 49,132 | -78.4% | 0.03% | -77.3% |
| Q4 2016 | $4,755,000 | -34.3% | 227,239 | -17.1% | 0.13% | -39.7% |
| Q3 2016 | $7,241,000 | +93.9% | 273,986 | +103.3% | 0.22% | +82.5% |
| Q2 2016 | $3,734,000 | – | 134,797 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |